Nonalcoholic fatty liver disease

Halina Cichoż-Lach

eISSN: 2450-4459
ISSN: 2450-3517

Lekarz POZ

Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors

Editorial System

Submit your Manuscript

2/2019
vol. 5

Send email

Copy url:

abstract:

Review paper

Nonalcoholic fatty liver disease

Halina Cichoż-Lach

¹

Klinika Gastroenterologii z Pracownią Endoskopową, Uniwersytet Medyczny w Lublinie

Online publish date: 2019/07/09

View full text Get citation

Nonalcoholic fatty liver disease (NAFLD) is now the most frequent chronic liver disease and the most frequent cause of the abnormal activity of aminotransferases. It affects about 25% of the global adult population. In the article the current principles of diagnosis and treatment of NAFLD are presented. The questions frequently asked by family doctors are answered, and the responses are thoroughly discussed. The role of ursodeoxycholic acid (UDCA) in the therapy of nonalcoholic steatohepatitis (NASH) is emphasised.

keywords:

Nonalcoholic fatty liver disease

Halina Cichoż-Lach 1

nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, diagnosis, treatment, ursodeoxycholic acid

Halina Cichoż-Lach

¹